The role of vitamin D supplementation in preventing multiple sclerosis (MS) and/or treating MS progression is an area of significant research interest. We detail the current status of the ongoing research in this field, and note the lack of class 1 evidence from well-conducted, large, double-blind, placebo-controlled studies of vitamin D supplementation in the prevention and/or treatment of MS. We have been able to provide some guidelines for practitioners based on the substantial burden of supportive evidence for the use of vitamin D in MS as summarised here. These guidelines may provide some support to those clinicians who treat people with MS and their families.

Item Type:	Refereed Article
Keywords:	Calcitriol, Cholecalciferol, Multiple sclerosis, Vitamin D
Research Division:	Medical and Health Sciences
Research Group:	Public Health and Health Services
Research Field:	Epidemiology
Objective Division:	Health
Objective Group:	Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:	Nervous System and Disorders
UTAS Author:	van der Mei, I (Associate Professor Ingrid van der Mei)
UTAS Author:	Taylor, BV (Professor Bruce Taylor)
ID Code:	85014
Year Published:	2013
Web of Science® Times Cited:	30
Deposited By:	Menzies Institute for Medical Research
Deposited On:	2013-06-11
Last Modified:	2014-04-17
Downloads:	0